Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A

scientific article published on July 1, 2003

Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/02791072.2003.10400021
P953full work available at URLhttp://www.tandfonline.com/doi/pdf/10.1080/02791072.2003.10400021
P698PubMed publication ID14621136

P2093author name stringWayne Briner
Mark Mowry
Michael Mosher
P2860cites workSalvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.Q33913584
Salvia divinorum and salvinorin A: new pharmacologic findingsQ34292784
Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorumQ56135973
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectgeneral psychologyQ1361345
P304page(s)379-382
P577publication date2003-07-01
P1433published inJournal of Psychoactive DrugsQ6295808
P1476titleAcute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A
P478volume35

Reverse relations

cites work (P2860)
Q30357121A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.
Q43842140Acute and post-acute behavioral and psychological effects of salvinorin A in humans
Q33269030Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement
Q34949512Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
Q34632744Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.
Q34451886New drugs of abuse
Q33725088Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace
Q37113859Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds
Q44350288Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates
Q34939810Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A
Q24656590Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents
Q44641835Salvia divinorum use and phenomenology: results from an online survey
Q38652778Salvia divinorum: An overview of the usage, misuse, and addiction processes
Q64062550Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action
Q28481482Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets
Q34820974Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model
Q34510909Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors
Q34514502The pharmacological effects of Salvia species on the central nervous system

Search more.